Related Experiment Video
Updated: Jul 16, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Accumulation of prion protein in the brain that is not associated with transmissible disease
Pedro Piccardo1, Jean C Manson, Declan King
1Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA.
Abstract:
Prion diseases or transmissible spongiform encephalopathies are characterized histopathologically by the accumulation of prion protein (PrP) ranging from diffuse deposits to amyloid plaques. Moreover, pathologic PrP isoforms (PrP(Sc)) are detected by immunoblot analysis and used both as diagnostic markers of disease and as indicators of the presence of infectivity in tissues. It is not known which forms of PrP are associated with infectivity. To address this question, we performed bioassays using human brain extracts from two cases with phenotypically distinct forms of familial prion disease (Gerstmann-Sträussler-Scheinker P102L). Both cases had PrP accumulations in the brain, but each had different PrP(Sc) isoforms. Only one of the brains had spongiform degeneration. Tissue from this case transmitted disease efficiently to transgenic mice (Tg PrP101LL), resulting in spongiform encephalopathy. In contrast, inoculation of tissue from the case with no spongiform degeneration resulted in almost complete absence of disease transmission but elicited striking PrP-amyloid deposition in several recipient mouse brains. Brains of these mice failed to transmit any neurological disease on passage, but PrP-amyloid deposition was again observed in the brains of recipient mice. These data suggest the possible isolation of an infectious agent that promotes PrP amyloidogenesis in the absence of a spongiform encephalopathy. Alternatively, the infectious agent may be rendered nonpathogenic by sequestration in amyloid plaques, or PrP amyloid can seed amyloid accumulation in the brain, causing a proteinopathy that is unrelated to prion disease. Formation of PrP amyloid may therefore not necessarily be a reliable marker of transmissible spongiform encephalopathy infectivity.
Insights
Prion diseases involve prion protein (PrP) accumulation. This study found that PrP amyloid plaques in familial prion disease do not always indicate infectivity or cause spongiform encephalopathy.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Prion diseases, or transmissible spongiform encephalopathies, are characterized by prion protein (PrP) accumulation, with pathological PrP isoforms (PrPSc) serving as diagnostic markers.
- The relationship between specific PrP forms and infectivity remains unclear, necessitating further investigation into their roles in disease pathogenesis.
Purpose of the Study:
- To investigate the association between different forms of prion protein (PrP) accumulation and infectivity in familial prion disease.
- To determine if PrP amyloid deposition is a reliable indicator of transmissible spongiform encephalopathy infectivity.
Main Methods:
- Bioassays were conducted using human brain extracts from two distinct familial Gerstmann-Sträussler-Scheinker P102L prion disease cases.
- Transgenic mice (Tg PrP101LL) were inoculated with brain tissue, and disease transmission, spongiform degeneration, and PrP deposition patterns were analyzed.
Main Results:
- Tissue from a case with spongiform degeneration efficiently transmitted disease to mice, causing spongiform encephalopathy.
- Tissue from a case without spongiform degeneration showed minimal disease transmission but significant PrP-amyloid deposition in recipient mice.
- Subsequent passages in mice confirmed the absence of neurological disease transmission from the amyloid-depositing tissue, despite persistent PrP-amyloid accumulation.
Conclusions:
- PrP amyloidogenesis may occur independently of spongiform encephalopathy and prion disease infectivity.
- PrP amyloid deposition might not be a reliable marker for transmissible spongiform encephalopathy infectivity.
- An infectious agent could promote amyloid formation without causing disease, or be sequestered within plaques, rendering it non-pathogenic.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Neural Regulation

